Sign up to receive our twice-weekly e-Newsletter
The manufacture and distribution of the HIV protease inhibitor Agenerase (amprenavir) was
discontinued by GlaxoSmithKline (GSK) in October 2007
.
Agenerase has been replaced by the HIV PI Lexiva (fosamprenavir)
, also manufactured by GSK. Fosamprenavir is a pro-drug of amprenavir, which is used for treatment of HIV infection in combination with low-dose ritonavir and other antiretroviral drugs.
Information on the HIV PI Lexiva
.
FDA-approved HIV
and AIDS Treatments
Protease Inhibitors
PIs
non Nucleoside Reverse
Transcriptase Inhibitors
nNRTIs
Nucleoside / Nucleotide
Reverse Transcriptase Inhibitors
NRTIs
Fixed-dose Combinations
Entry / Fusion Inhibitors
EIs
Integrase Inhibitors
Experimental Treatments
HIV and AIDS
Articles by Topic
Adverse Events
Opportunistic Infections
Metabolic Complications
Lipodystrophy - Fat Redistribution
Treatment Guidelines
Women/Children
